Peter Kirk is an immuno-oncology research team leader with over 20 years of extensive biotech experience. Currently serving as Director at Immunocore, they focus on biomarker strategy and implementation for clinical trials. Previously, Kirk held positions at KaloBios and Nektar Therapeutics, where they contributed to the development of innovative protein therapeutics, including key roles in advancing immunotherapy biologics to clinical stages. They earned a D.Phil in Molecular Biology from the University of Oxford and a Master of Arts in Natural Sciences from the University of Cambridge.
This person is not in the org chart
This person is not in any teams
This person is not in any offices